A. Metzger

发表

Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis

H. Meiselman, P. Moriarty, E. S. Harris, 2018, Journal of scleroderma and related disorders.

Therapeutic Plasma Exchange for the Treatment of Raynaud ' s and Digital Ulcers in Systemic Sclerosis : A Systematic Review

H. Meiselman, P. Moriarty, E. S. Harris, 2016 .

Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center.

D. Wallace, C. Azen, S. Nessim, 1995, Seminars in arthritis and rheumatism.

Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy.

C. Pearson, L. Goldberg, A. Metzger, 1974, Annals of internal medicine.

Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases

R. Morris, E. Kang, A. Metzger, 2008, Lupus.

Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome.

Pojen P. Chen, M. Weisman, D. Wallace, 2005, Arthritis and rheumatism.

Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection.

R. Morris, K. Sherman, A. Metzger, 2005, The Journal of rheumatology.

HL-A W27 in psoriatic arthropathy.

R. Morris, P. Terasaki, A. Metzger, 1975, Arthritis and rheumatism.

HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease.

R. Morris, P. Terasaki, A. Metzger, 1974, The New England journal of medicine.

Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27.

J. Edmonds, R. Morris, P. Terasaki, 1974, Annals of the rheumatic diseases.

The prevalence of autoantibodies in symptomatic and asymptomatic patients with breast implants and patients with fibromyalgia.

R. Morris, O. Gluck, J. Tesser, 1996, Current topics in microbiology and immunology.

Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features.

D. Wallace, M. Pistiner, S. Nessim, 1992, Seminars in arthritis and rheumatism.

Lupus erythematosus in the 1980s: a survey of 570 patients.

D. Wallace, M. Pistiner, S. Nessim, 1991, Seminars in arthritis and rheumatism.

Cyclosporine for lupus membranous nephritis:experience with ten patients and review of the literature

D. Wallace, J. Klinenberg, J. Klinenberg, 2000, Lupus.

Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis

D. Wallace, H. Euler, D. Goldfinger, 1998, Journal of clinical apheresis.

Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids.

D. Wallace, V. Stecher, P. Kern, 1990, The American journal of medicine.

Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus.

J. Klinenberg, A. Metzger, D. Wallace, 2001, Clinical immunology.

Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma.

C. Pearson, F. Singer, A. Metzger, 1974, The New England journal of medicine.

The Relevance of Antimalarial Therapy with Regard to Thrombosis, Hypercholesterolemia and Cytokines in SLE

D. Wallace, V. Stecher, A. Metzger, 1993, Lupus.

Proceedings: HL-A antigen W27 in juvenile chronic polyarthritis.

J. Edmonds, P. Terasaki, B. Ansell, 1974, Annals of the rheumatic diseases.

Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.

R. Morris, P. Grimes, T. Soriano, 2004, Journal of the American Academy of Dermatology.

Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis

G. Pruijn, R. Morris, W. Schlumberger, 2016, Autoimmunity Highlights.

Combination immunosuppressive treatment of steroid-resistant dermatomyositis/polymyositis.

D. Wallace, A. Metzger, K. White, 1985, Arthritis and rheumatism.

Therapeutic Plasma Exchange for the Treatment of Systemic Scleroderma : A Comprehensive Review and Analysis

H. Meiselman, P. Moriarty, E. S. Harris, 2016 .

Performance of Anti–Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting

D. Khanna, V. Nagaraja, J. Warren, 2018, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis.

H. Paulus, D. Furst, A. Metzger, 1977, Arthritis and rheumatism.

HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome.

R. Morris, P. Terasaki, A. Metzger, 1974, The New England journal of medicine.

Tubular structures in endothelium in palindromic rheumatism.

D. Mccarty, A. Metzger, Z. Molnar, 1972, Arthritis and rheumatism.

Reversible cause of back pain and sciatica in rheumatoid arthritis: an apophyseal joint cyst.

D. Resnick, M. Weisman, H. Dorfman, 1986, Arthritis and rheumatism.

Gonococcal Arthritis Complicating Gonorrheal Pharyngitis

A. Metzger, 1970 .

Anti-telomere antibodies in systemic lupus erythematosus: a new ELISA test for anti-DNA with potential pathogenetic implications

D. Wallace, R. Morris, E. Salonen, 2000, Lupus.

Reversible Cerebral Oedema Complicating Diabetic Ketoacidosis

A. Rubenstein, A. Metzger, 1970, British medical journal.

Can an earthquake cause flares of rheumatoid arthritis or lupus nephritis?

D. Wallace, A. Metzger, 1994, Arthritis and rheumatism.

Osteoporosis--less than expected in patients with scleroderma?

D. Wallace, A. Metzger, K. Neumann, 2000, The Journal of rheumatology.

Gonococcal arthritis complicating gonorrheal pharyngitis.

A. Metzger, 1970, Annals of Internal Medicine.

Multicentric reticulohistiocytosis (lipoid dermato-arthritis). An erosive polyarthritis with distinctive clinical, roentgenographic and pathologic features.

J. Mirra, R. Gold, A. Metzger, 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.

Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines

J. Fries, J. Drijfhout, W. Robinson, 2006, Annals of the rheumatic diseases.

Computer-Assisted Pattern Recognition of Autoantibody Results

Mark C. Genovese, M. Genovese, J. Merrill, 2005, Clinical Diagnostic Laboratory Immunology.

Sensitivity and clinical utility of the anti-cytosolic 5′-nucleotidase 1A (cN1A) antibody test in sporadic inclusion body myositis: Report of 40 patients from a single neuromuscular center

Daniel T. Larose, Charles H. Whitaker, D. Larose, 2018, Neuromuscular Disorders.

Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMC.

R. Mandyam, J. Klinenberg, A. Metzger, 1999, Clinical immunology.

A physiological method for estimation of hepatic secretion of biliary lipids in man.

S. Grundy, A. Metzger, A. L. Metzger, 1972, Gastroenterology.

NSAID usage patterns by rheumatologists in the treatment of SLE.

D. Wallace, J. Klinenberg, A. Metzger, 1989, The Journal of rheumatology.

cytokines associated with up regulation of proinflammatory rheumatoid arthritis : anti-citrulline autoreactivity is Proteomic analysis of secreted proteins in early

J. Fries, J. Drijfhout, W. Robinson, 2007 .

cytokineswith up regulation of proinflammatory rheumatoid arthritis: anti-citrulline autoreactivity is Proteomic analysis of secreted proteins in early

J. Fries, J. Drijfhout, W. Robinson, 2007 .

A Comparison of Systemic Lupus Erythematosus and Scleroderma Patients with and without Silicone Breast Implants

D. Furst, D. Wallace, P. Clements, 1996, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.